Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CHIASMA, INC | 4,257,978 | reported | 21 Jul 2015 | tx 8+5,681,544−51,883,882 |
| Pacira BioSciences, Inc. | 2,828,941 | reported | 08 Feb 2011 | tx 6+2,735,961−2,200,247 |
| Conatus Pharmaceuticals Inc | 20,000 | reported | 21 Jun 2018 | tx 12+1,344,300−8,599,171 |
| Aligos Therapeutics, Inc. | 5,860 | reported | 25 Jun 2025 | tx 9+414,307−30,000 |
| PEPLIN INC | 0 | reported | 11 Nov 2009 | tx 21+33,910−3,712,930 |
| TriVascular Technologies, Inc. | 0 | reported | 03 Feb 2016 | tx 15+12,091,001−58,665,405 |
| Avalanche Biotechnologies, Inc. | 0 | reported | 09 Dec 2025 | tx 24+439,304−128,803 |
| DICE Therapeutics, Inc. | 0 | reported | 09 Aug 2023 | tx 23+102,049−151,890 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Dec 2025 | TENDER | Avalanche Biotechnologies, Inc. | 10,333 | — | |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 4,000 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 4,000 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 4,000 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 3,000 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 4,500 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 4,666 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 10,450 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 10,520 | — | deriv |
| 25 Jun 2025 | GRANT_AWARD | Aligos Therapeutics, Inc. | 5,860 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | Avalanche Biotechnologies, Inc. | 10,450 | 0.00 USD | deriv |
| 27 Jun 2024 | GRANT_AWARD | Aligos Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 17 Jun 2024 | GRANT_AWARD | Avalanche Biotechnologies, Inc. | 10,520 | 0.00 USD | deriv |
| 28 Feb 2024 | GRANT_AWARD | Aligos Therapeutics, Inc. | 8,823 | 0.00 USD | deriv |
| 27 Feb 2024 | OTHER | Aligos Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 07 Feb 2024 | PURCHASE | Avalanche Biotechnologies, Inc. | 100,000 | 1.35 USD | first after silence |
| 25 Oct 2023 | GRANT_AWARD | Aligos Therapeutics, Inc. | 183,083 | 0.76 USD | |
| 25 Oct 2023 | GRANT_AWARD | Aligos Therapeutics, Inc. | 91,541 | 0.13 USD | deriv |
| 09 Aug 2023 | OTHER | DICE Therapeutics, Inc. | 25,722 | — | |
| 09 Aug 2023 | OTHER | DICE Therapeutics, Inc. | 15,199 | — | |
| 09 Aug 2023 | OTHER | DICE Therapeutics, Inc. | 12,096 | — | deriv |
| 09 Aug 2023 | OTHER | DICE Therapeutics, Inc. | 8,261 | — | deriv |
| 09 Aug 2023 | OTHER | DICE Therapeutics, Inc. | 13,800 | — | deriv |
| 09 Aug 2023 | OTHER | DICE Therapeutics, Inc. | 21,250 | — | deriv |
| 02 Aug 2023 | GIFT | DICE Therapeutics, Inc. | 2,200 | 0.00 USD |
4 purchases reported after at least 12 months of silence — most recent on 07 Feb 2024.